Loading clinical trials...
Loading clinical trials...
Safety, Effectiveness and Durability of Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China
Conditions
Interventions
Transcatheter Aortic Valve Replacement (TAVR)
Locations
4
China
Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University
Xi'an, Shaanxi, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Fuwai Hospital, Chinese Academy of Medical Sciences
Beijing, China
Shanghai Zhongshan Hospital, Fudan University
Shanghai, China
Start Date
April 24, 2025
Primary Completion Date
June 30, 2031
Completion Date
June 30, 2031
Last Updated
June 19, 2025
NCT02306200
NCT06597188
NCT06753227
NCT07273669
NCT07450196
Lead Sponsor
Xijing Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions